Clinicopathological Correlation of Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study
Open Access
- 10 November 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6659
Abstract
The pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is largely unknown. Although pulmonary endarterectomy (PEA) is potentially curative, inoperable patients and persistent pulmonary hypertension (PH) following surgery remain a significant problem. In this study, we aim to describe the histopathological characteristics of CTEPH and explore the potential relationship between pulmonary arterial lesions, radiological parameters, and clinical manifestations. Endarterectomized tissues from 81 consecutive patients of CTEPH were carefully collected, sectioned, and examined by experienced pathologists. Pertinent clinical and radiological data were obtained from medical records and operative reports. Neointima, fresh/organized thrombi, recanalized regions, and atherosclerotic lesions were microscopically examined as previously described. Thrombi and atherosclerosis were dominant in UCSD classification level I PEA materials, while recanalized neo-vessels were more frequently observed in UCSD classification level III cases. Degenerative changes of the extracellular matrix were also noticed in the vascular bed. Atherosclerotic lesions were more frequently observed in cases with higher ratio of the pulmonary artery diameter to ascending aorta diameter (PA/AA) reflected by computed tomographic pulmonary arterial scanning. Furthermore, the removal of pulmonary artery complex lesions (with the combination of three to four types of lesions) by PEA was associated with lower postoperative mean pulmonary arterial pressure (mPAP) and decreased incidences of persistent PH. Our study demonstrates that the histopathological features of CTEPH are strongly linked with clinical manifestations and the postoperative outcome after PEA. These data may provide possible evidence for further studies in searching for appropriate causal factors underlying this disease.Keywords
Funding Information
- the CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-049)
- National Natural Science Foundation of China (81970058)
- non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT320-001, 2021-RC310-016)
- CAMS Innovation Fund for Medical Sciences (2022-I2M-C, T-B-108)
This publication has 23 references indexed in Scilit:
- Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2015
- Endothelial-to-Mesenchymal Transition in Pulmonary HypertensionCirculation, 2015
- Thrombosis formation on atherosclerotic lesions and plaque ruptureJournal of Internal Medicine, 2014
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Circulation, 2011
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registryThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Long-term Outcome after Pulmonary EndarterectomyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Prediction of Moderate or Severe Pulmonary Hypertension by Main Pulmonary Artery Diameter and Main Pulmonary Artery Diameter/Ascending Aorta Diameter in Pulmonary EmbolismCardiology in Review, 2006
- Chronic Thromboembolic Pulmonary HypertensionCirculation, 2006
- An Association between Atherosclerosis and Venous ThrombosisNew England Journal of Medicine, 2003
- Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomyThe Journal of Thoracic and Cardiovascular Surgery, 2002